Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models

BACKGROUND: DNA vaccines represent an attractive approach for cancer treatment by inducing active T cell and B cell immune responses to tumor antigens. Previous studies have shown that interleukin-13 receptor α2 chain (IL-13Rα2), a tumor-associated antigen is a promising target for cancer immunother...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nakashima, Hideyuki, Fujisawa, Toshio, Husain, Syed R, Puri, Raj K
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993653/
https://ncbi.nlm.nih.gov/pubmed/21067607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky